Telomerase: Dr Jekyll or Mr Hyde?

Current Opinion in Genetics and Development

Volumn 9, Issue 3, 1999, Pages 368-373

  Prescott, John C ^a   Blackburn, Elizabeth H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

CARCINOGENESIS; CELL; CELL DIVISION; ENZYME ACTIVATION; ENZYME ACTIVITY; LIFESPAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW;

EID: 0033151958     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)80055-0     Document Type: Article

References (61)

1. Blackburn EH: Structure and function of telomeres. Nature 1991. 350:569-573.
2. Zakian VA: Telomeres: Beginning to understand the end. Science 1995, 270:1601-1607.
3. Autexier C, Greider CW: Telomerase and cancer: Revisiting the telomere hypothesis. Trends Biochem Sci 1996, 21:387-391.
4. Greider CW: Telomeres and senescence: The history, the experiment, the future. Curr Biol 1998, 8:R178-R181.
5. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991, 256:271-282.
6. Greider CW: Telomere length regulation. Annu Rev Biochem 1996, 65:337-365.
7. Nugent CI, Lundblad V: The telomerase reverse transcriptase: Components and regulation. Genes Dev 1998, 12:1073-1085.
8. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
9. Zakian VA: Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 1996, 30:141-172.
10. HayfLick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
11. Harley CB, Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5:249-255.
12. Singer MS, Gottschling DE: TLC1: Template RNA component of Saccharomyces cerevisiae telomerase. Science 1994, 266:404-409.
13. Prescott J, Blackburn EH: functionally interacting telomerase RNAs in the yeast telomerase complex. Genes Dev 1997, 11:2790-2800.
14. Cohn M, Blackburn EH: Telomerase in yeast Science 1995, 269:396-400.
15. Lingner J, Cech TR, Hughes TR, Lundblad V: Three ever shorter telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc Natl Acad Sci USA 1997, 94:11190-11195.
16. Weinrich SL, PRuzan R, Ma L, Ouellette M, Tesmer VM, Holt Se, Bodnar AG, LichtSteiner S, Kim NW, Trager JB, et al.: Reconstitution of human telomerase with the template RNA component hTr and the catalytic protein subunit hTRT. Nat Genet 1997, 17:498-502.
17. Beattie TL, Zhou W, Robinson MO, Harrington L: Reconstitution of human telomerase activity in vitro. Curr Biol, 1998, 8:177-180. This and the previous report [16•] demonstrate that the TER RNA subunit and the TERT protein subunit are, by themselves, sufficient for core telomerase catalysis. This report further demonstrates that a large portion of the TER RNA subunit of telomerase is not required for core telomerase activity.
18. Collins K, Gandhi L: The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. Proc Natl Acad Sci USA 1998, 95:8485-8490.
19. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996. 56:645-650.
20. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT: Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996. 56:3796-3802.
21. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996, 12:200-204.
22. MEyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q et al.: hEst2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997, 90:785-795.
23. Kolquist KA, Ellisen LW, Counter CM, MEyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL: Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998, 19:182-186.
24. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994, 91:2900-2904.
25. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, LichtSteiner S, Wright WE: Extension of lifespan by introduction of telomerase into normal human cells. Science 1998, 279:349-352. Together with [28••], demonstrates that expression of TERT is sufficient to extend the lifespan of at least some cell types, providing the first direct support for the telomere hypothesis of replicative senescence.
26. Wang J, Xie LY, Allan S, Beach D, Hannon GJ: Myc activates telomerase. Genes Dev 1998, 12:1769-1774.
27. Counter CM, Hahn WC, WEi W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA: Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 1998, 95:14723-14728. Together with [30••], demonstrates that expression of TERT is sufficient to immortalize at least some post M1 SV40 T-Ag transformed cells.
28. Vaziri H, Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998, 8:279-282. See annotation [25••].
29. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396:84-88. This report highlights the cell specificity in telomerase-mediated replicative lifespan extension. Whereas epithelial cells require inactivation of pRb in order for exogenous telomerase activity to extend the cell's replicative potential, fibroblasts were immortalized by telomerase alone.
30. Zhu J, Wang H, Bishop JM, Blackburn EH: Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999, 96:3723-3728. See annotation [27••]. A further demonstration that telomere lengthening is not necessary for telomerase-mediated replicative lifespan extension, supporting a role for telomerase in telomere stabilization in addition to its role in the synthesis of telomeric DNA.
31. Morales CP, Holt SE, Ouellette M, Kaur KJ, VAN Y, Wilson KS, White MA, Wright WE, Shay JW: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999, 21:115-118. Together with [32••], demonstrates that cells expressing exogenous telomerase and maintained in culture long-term (i.e. telomerase-immortalized cells) retain normal growth controls (serum dependence, anchorage dependence, and contact inhibition), and a normal karyotype. This study further demonstrates that inactivation of p53 and pRb are not sufficient to confer anchorage-independent growth to telomerase-immortalized cells.
32. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD et al.: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999. 21:111-114. See annotation [31••]. This study further demonstrates that telomerase-immortalized cells are not tumorigenic in vivo.
33. Lundblad V, Szostak JW: A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989, 57:633-643.
34. Lendvay TS, Morris DK, Sah J, BalasuBramanian B, Lundblad V: Sequence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 1996, 144:1399-1412.
35. KrAuskopf A, Blackburn EH: Rap1 protein regulates telomere turnover in yeast. Proc Natl Acad Sci USA 1998, 95:12486-12491.
36. Marcand S, Gilson E, Shore D: A protein-counting mechanism for telomere length regulation in yeast. Science 1997, 275:986-990.
37. McEachern MJ, Blackburn EH: Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995, 376:403-409.
38. McEachern MJ, Blackburn EH: Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev 1996, 10:1822-1834.
39. Lundblad V, Wright WE: Telomeres and telomerase: A simple picture becomes complex. Cell 1996, 87:369-375.
40. Nakamura TM, Cooper JP, Cech TR: Two modes of survival of fission yeast without telomerase. Science 1998, 282:493-496.
41. Promisel Cooper J, Nimmo ER, Allshire RC, Cech TR: Regulation of telomere length and function by a myb-domain protein in fission yeast. Nature 1997, 385:744-747.
42. Van Steensel B, De Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385:740-743.
43. Van Steensel B, SmogorzewskA A, De Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413. Demonstrates that TRF2 plays a key role in protecting the telomeres from end-to-end fusions and that (TTAGGG)-repeat DNA is not sufficient for the integrity and function of human telomeres.
44. KrAuskopf A, Blackburn EH: Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats. Nature 1996, 383:354-357.
45. SMith S, Giriat I, Schmitt A, De Lange T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998, 282:1484 1487.
46. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11:1921-1929.
47. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S: Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68:3410-3414.
48. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK: Restoration of telomeres in human papiliomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 1994, 14:961-969.
49. Hande MP, SampEr E, LansdorP P, Blasco MA: Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 1999, 144:589-601.
50. Prescott J, Blackburn EH: Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev 1997, 11:528-540.
51. Blasco MA, Lee HW, Hande MP, SampEr E, Lansdorp PM, DePinho RA, Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
52. Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW, DePinho RA: Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
53. Niida H, MaTsumoTo T, SatoH H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y: Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet 1998, 19:203-206.
54. -/- embryos is associated with failure to close the neural tube. EMBO J 1999, 18:1172-1181. First demonstration of a clear developmental defect in mice lacking telomerase. mTR knockout mice have an increased frequency of death in utero that correlates with both telomere shortening and a failure to close the neural tube.
55. Bryan TM, Englezou A, DaLLa-Pozza L, Dunham MA, Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997, 3:1271-1274.
56. Lundblad V, Blackburn EH: An alternative pathway for yeast telomere maintenance rescues est1 -senescence. Cell 1993, 73:347-360.
57. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blut ML, O'Kane DJ: Comparison of screening methods in the detection of bladder cancer. J Urol 1999, 161:388-394. A comparison of the sensitivity and specificity of a variety of methods for detecting bladder malignancy in cells present in urine samples. Urinary telomerase showed the highest level of sensitivity and specificity as a predictor of bladder cancer.
58. Kyo S, Kanaya T, IsHikawa H, Ueno H, Inoue M: Telomerase activity in gynecological tumors. Clin Cancer Res 1996, 2:2023-2028.
59. Wisman GB, HOllema H, De Jong S, Ter Schegget J, Tjong A, Hung SP, Ruiters MH, Krans M, De Vries EG, Van der Zee AG: Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear. J Clin Oncol 1998, 16:2238-22345.
60. Wynn RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG: Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998, 351:178-181.
61. Stevenson RL: The Strange Case of Dr. Jekyll and Mr. Hyde. New York: Scribner's Sons; 1886.